Skip to content
value.today

Eyenovia, Inc.

🇺🇸 Tampa, Florida, USAHealth CareFounded 2014
Total raised
$10 M
2 rounds on record
Latest round
$6 M
Jul 2017
First round on record
Jul 2016
Today
Went public
See the company page

Eyenovia, Inc. is listed today as Hyperion Defi, Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Eyenovia, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2025$50 MPrivate placement after listing$50 to $250 million

Eyenovia, Inc.: Private sale, Jun 2025

Investors in this round

5 investors had bought by the notice of Jul 22, 2025: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$50 M of $50 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$3,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hyunsu Jung · Executive Officer, Director
  • Michael Rowe · Executive Officer, Director
  • Ellen Strahlman · Director
  • Michael Geltzeiler · Director
  • Rachel Jacobson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Chardan Capital Markets, LLC (CRD 000120128) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Represents 6% of the transaction's gross proceeds issued as 307,692 shares of preferred stock to purchase 923,076 shares of common stock and warrants to purchase 1,846,153 shares of common stock. The conversion and exercise price are both $3.25 per share.”

Signed by Michael Rowe, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Jul 22, 2025. Read the notice at the SEC.

equity, optionsSEC
Mar 2020$6 MPrivate placement after listing$2 to $10 million

Eyenovia, Inc.: Private sale, Mar 2020

Investors in this round

82 investors had bought by the notice of Apr 7, 2020: 82 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$15,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$340,794
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Gandolfo · Executive Officer · Chief Financial Officer
  • Tsontcho Ianchulev · Executive Officer, Director · Chief Executive Officer
  • Anthony Sun · Director
  • Charles Mather · Director
  • Curt LaBelle · Director
  • Ernest Mario · Director
  • Fredric Eshelman · Director
  • Kenneth Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · New York, New YorkSold in all US states

Signed by John P. Gandolfo, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 7, 2020. Read the notice at the SEC.

equity, optionsSEC
Jul 2017$6 MNo. 2$2 to $10 million

Eyenovia, Inc.: Raise no. 2, Jul 2017

Investors in this round

10 investors had bought by the notice of Aug 14, 2017: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $20 M offered; $14 M still to sell
Smallest investment taken
$34,687
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Curt Labelle · Executive Officer, Director
  • Tsontcho Ianchulev · Executive Officer, Director
  • Ernest Mario · Director
  • Fred Eshelman · Director
  • Shuhei Yoshida · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tsontcho Ianchulev, Ceo. Source: SEC Form D, newest notice filed Aug 14, 2017. Read the notice at the SEC.

equity, optionsSEC
Jul 2016$4 MNo. 1$2 to $10 million

Eyenovia, Inc.: Raise no. 1, Jul 2016

Investors in this round

4 investors had bought by the notice of Aug 24, 2016: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $8 M offered; $4 M still to sell
Smallest investment taken
$411,902
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Butler · Executive Officer
  • Curt Labelle · Executive Officer, Director
  • Tsontcho Ianchulev · Executive Officer, Director
  • Ernest Mario · Director
  • Fred Eshelman · Director
  • Shuhei Yoshida · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Tsontcho Ianchulev, Ceo. Source: SEC Form D, newest notice filed Aug 24, 2016. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Hyperion Defi, Inc., its revenue in fiscal 2025 came from these business segments: Digital Assets $800,000 (98%), Ophthalmic Technology $10,000 (2%).

    Annual report (SEC XBRL) · Dec 2025

  • Eyenovia, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2025).

    SEC Form D · Jul 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2025

Products and services#

No products or services of Eyenovia, Inc. are on record.

Investors#

No investor of Eyenovia, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.

Largest shareholders today

Institutions holding Hyperion Defi, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Eyenovia, Inc.
NameRoleNamed in
Hyunsu JungExecutive officerJul 2025
Michael RoweExecutive officerJul 2025
John GandolfoChief Financial OfficerApr 2020
Tsontcho IanchulevChief Executive OfficerApr 2020
Curt LabelleExecutive officerAug 2017
Barry ButlerExecutive officerAug 2016
Ellen StrahlmanDirectorJul 2025
Hyunsu JungDirectorJul 2025
Michael GeltzeilerDirectorJul 2025
Michael RoweDirectorJul 2025
Rachel JacobsonDirectorJul 2025
Anthony SunDirectorApr 2020
Charles MatherDirectorApr 2020
Curt LaBelleDirectorApr 2020
Ernest MarioDirectorApr 2020
Fredric EshelmanDirectorApr 2020
Kenneth LeeDirectorApr 2020
Tsontcho IanchulevChief Executive OfficerApr 2020
Curt LabelleDirectorAug 2017
Fred EshelmanDirectorAug 2017
Shuhei YoshidaDirectorAug 2017

Went public since 2018. Its SEC number is that of a company listed on a stock exchange.